Does LORLATINIB Cause Pneumonitis? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Pneumonitis have been filed in association with LORLATINIB (Lorbrena). This represents 1.0% of all adverse event reports for LORLATINIB.
57
Reports of Pneumonitis with LORLATINIB
1.0%
of all LORLATINIB reports
15
Deaths
24
Hospitalizations
How Dangerous Is Pneumonitis From LORLATINIB?
Of the 57 reports, 15 (26.3%) resulted in death, 24 (42.1%) required hospitalization, and 12 (21.1%) were considered life-threatening.
Is Pneumonitis Listed in the Official Label?
Yes, Pneumonitis is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Pneumonitis?
NIVOLUMAB (2,076)
PEMBROLIZUMAB (1,933)
METHOTREXATE (1,188)
PACLITAXEL (1,110)
CARBOPLATIN (975)
EVEROLIMUS (919)
IPILIMUMAB (891)
ATEZOLIZUMAB (842)
DURVALUMAB (827)
RITUXIMAB (747)
Which LORLATINIB Alternatives Have Lower Pneumonitis Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE